4 stories this morning, for surgeons and the people who support them.
- OIG: Medicare improperly paid $15.2M for SI joint injections, with 72% of sampled sessions non-compliant — Audit covering Oct 2023–Sep 2024 found 72% of sampled sacroiliac joint injection sessions failed one or more Medicare requirements; 25% were billed as therapeutic when the documentation supported diagnostic. Distinct from the separate facet-joint audit, which put improper payments near $29.6M. Source
- Globus Medical Q2 2026: $789.6M net sales, US spine +7%, international spine +14% — Quarterly net sales up 5.9% year over year, with international outgrowing the US book by two to one. Source
- OrthoPediatrics buys a UK spinal device manufacturer, expanding its scoliosis line — OrthoPediatrics EU Limited acquired all share capital of a UK maker of devices for spinal disorders in July 2026, adding to the scoliosis portfolio and enlarging its European footprint. Source
- Dr. Vin Dasa on the rep-less debate: the real question is coverage, and the technology exists — Posting on LinkedIn, Dasa notes he helped build case-coverage and inventory automation 5–10 years ago inside a large health system, and that the market demand wasn't there. His framing: not whether reps disappear, but whether one rep can cover three to five rooms instead of one. Source
Contribute to the Brief
Faculty can send the show a note — a reaction to a paper, a correction, a read on a rule change — either written, which we shape for broadcast and read in the show's voice, or as a voice note under three minutes, which airs in your own voice. Send one from Studio.
Not on doc social yet? Contribute a lecture or join the network — doc social is a clinical education platform for clinicians, and this show is one part of it.
Narration is synthesized. Reporting and editorial judgement are ours, and every story above links to its source.